CGuard EPS
Commercial- Indications
- Carotid artery disease
Company intelligence / Profile preview
InspireMD
Miami, Florida, United Statesinspiremd.com ↗
- Ownership
- Public · NSPR
- Employees
- ~66
- Development stage
- Commercial
01
Overview
InspireMD’s lead product CGuard® Prime EPS has received CE Mark approval under the European MDR for the prevention of stroke in patients with carotid artery disease. The system uses a proprietary MicroNet™ mesh to provide sustained embolic protection by trapping debris and preventing plaque prolapse during stenting procedures. Clinical data demonstrate lasting protection beyond five years in Europe. U.S. launch anticipated in 2025 pending FDA approval[7][1][6].
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Device
- Industry
- Implantable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Local distribution partners across Europeno major pharma/biotech partnerships disclosed
04
Financials
- Market cap
- $38.9M
- Total revenue
- $1.8M
- Enterprise value
- $10.4M
Beyond the preview
Go deeper on InspireMD.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InspireMD.